Abstract

BackgroundEltrombopag is a thrombopoietin receptor agonist (TRA). The drug has been approved for the treatment of chronic immune thrombocytopenia (ITP). The platelet (PLT) count response is usually maintained as long...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call